Supramolecular nanomedicine for selective cancer therapy via sequential responsiveness to reactive oxygen species and glutathione
Keyword(s):
A supramolecular nanomedicine that is sequentially responsive to ROS and GSH was developed to specifically deliver chemotherapeutic agents to cancer cells.
Keyword(s):
2013 ◽
Vol 19
(16)
◽
pp. 4309-4314
◽
Keyword(s):
Keyword(s):
2019 ◽
Vol 18
(9)
◽
pp. 1313-1322
◽
2014 ◽
Vol 14
(7)
◽
pp. 1051-1061
◽
Keyword(s):
2008 ◽
Vol 84
(11)
◽
pp. 945-955
◽
2017 ◽
Vol 277
◽
pp. 137-144
◽